J&J partner Legend Biotech looks to raise $350M amid Carvykti rollout, global expansion
Legend Biotech, Johnson & Johnson’s partner on closely watched CAR-T therapy Carvykti, is looking for additional funding as the drug launches and the Chinese biotech’s global expansion kicks into gear.
The biotech is looking to raise $350 million from selling over 8 million American Depositary Shares at a public offering price of $43 each. The deal would also have a 30-day option for underwriters to buy an additional 1.22 million shares, according to a recent company statement. read more
